-45%

est. 2Y upside i

HealthcareSeries D+

We automate operations for hospitals and health systems

Rank

#1742

Sector

Healthcare Technology

Est. Liquidity

~3Y

Data Quality

Data: High

Qventus operates in a massive and fast-growing healthcare AI market (TAM $928.2B, growing ~38% YoY), with recent recognition as a leader in its space.

Last updated: March 10, 2026

Bull (25%)+200%

Qventus successfully leverages its Oracle partnership and AI Solution Factory to achieve significant market expansion and capture substantial share in the rapidly growing healthcare AI market. Revenue scales to over $150M by 2028, justifying a premium valuation of $1.2B (3x current) due to proven ROI and market leadership.

Base (35%)+75%

Qventus maintains a strong growth trajectory, expanding its customer base and product offerings in hospital operations. Revenue reaches approximately $70M-$90M by 2028, leading to a valuation of $700M, reflecting continued market adoption and a stable revenue multiple.

Bear (40%)-50%

Intense competition from dominant incumbents like Epic and other well-funded healthcare AI startups, coupled with challenges in achieving profitability, significantly limits Qventus's growth. This leads to a down round or an acquisition at a reduced valuation of $200M, severely impacting common stock value due to liquidation preferences.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

50%

Investors hold $201M in liquidation preferences, meaning common stock holders would receive little to nothing in an exit at or below $201M, and significantly diluted returns between $201M and $400M.

Dilution Risk

high

As a Series D company not yet profitable, future funding rounds are likely, which will dilute existing equity holders.

Secondary Liquidity

moderate

Accredited investors can buy and sell Qventus shares on secondary markets like UpMarket and EquityZen, offering some liquidity for existing shareholders.

Questions to Ask at the Interview

Strategic questions based on Qventus's data — designed to show you've done your homework.

  • 1

    “How does the recent partnership with Oracle impact Qventus's long-term competitive strategy, particularly concerning the incumbent threat from other major EHR vendors like Epic?”

  • 2

    “With the launch of the AI Solution Factory and new automation suites, what are the key metrics the company is tracking to demonstrate ROI for health systems and how does that translate into revenue growth and profitability?”

  • 3

    “Given the Series D funding and the current market conditions, what is the anticipated timeline and most likely exit scenario for Qventus, and how does the company plan to manage potential dilution for employees in future funding rounds?”

Community

Valuation Sentiment

Our model estimates -45% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.